Aslan Pharmaceuticals Pte Ltd

ASLAN Pharmaceuticals focuses its clinical research on atopic dermatitis, with attention to patients living with persistent inflammatory skin disease and ongoing symptom burden.

• Moderate-to-severe atopic dermatitis
• Inflammatory skin disorders
• Chronic pruritic disease

The sponsor’s current research activity is centered on treatment options for individuals who have previously received dupilumab, reflecting interest in difficult-to-manage dermatologic disease.